Abstract

Sepsis is a common problem in hospital practice. As well as being an important precipitant of hospital admission many patients develop the problem after arrival in hospital, including in excess of 500,000 patients in critical care units across each year. Over one-half of all infections in critical care units are associated with severe sepsis or septic shock.1 Despite major research effort in this area and the introduction of new therapeutic agents, mortality from septic shock remains high (50-70%). With the ageing population, emerging antibiotic resistance, and increasing use of immunosuppressive healthcare, sepsis is set to become an even greater drain on healthcare resources. The early recognition and appropriate management of sepsis is important. There is increasing evidence that an immediate, proactive approach has prognostic significance.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Alberti C, Brun-Buisson C, Burchardi H, et al; Epidemiology of sepsis and infection in ICU patients from an international multicenter cohort study. Intensive Care Med 2002; 28: 108-121.
2. Bone RC, Balk RA, Cerra FB, et al; American College of Chest Physicians / Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 20: 864-874.
3. Vincent JL, Bihari DJ, Suter PM, et al; The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274: 639-644.
4. Hack CE, Zeerlander S; The endothelium in sepsis; source of and a target for inflammation. Crit Care Med 2001; 29(suppl): S21-S27.
5. Herbert PC, Wells G, Blajchman MA, et al; A multicenter, randomised, controlled clinical trial of transfusion requirements in critical care. NEJM 1999; 340: 409-417.
6. Kellum JA, Decker JM; Use of dopamine in acute renal failure: A metaanalysis. Crit Care Med 2001; 29: 1526-1531.
7. Griffiths RD, Jones C, Palmer TE; Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13: 295-302.
8. Hill AV; The genomics & genetics of human infections and disease susceptibility. Annu.Rev.Genomics Hum.Genet 2001; 2: 373-400.
9. Bernard GR, Vincent JL, Laterre PF, et al; Efficacy and safety of recombinant human activated protein C for severe sepsis. PROWESS study group. NEJM 2001; 344: 699-709.
10. Zaloga GP; Sepsis-induced adrenal deficiency syndrome. Crit Care Med 2001; 29: 688-690.
11. Cronin L, Cook DJ, Carlet J, et al; Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23: 1430-1439.
12. Annane D; Corticosteroids for septic shock. Crit Care Med 2001; 29(suppl): S117-S120.
13. Van Den Berghe G, Wouters P, Weekers F, et al; Intensive insulin therapy in critically ill patients. NEJM 2001; 345: 1359-1367.
14. Tsuneyoshi I, Yamada H, Kakihana Y, et al; Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487-493.
15. Rivers E, Nguyen B, Havstad S, et al; Early goal-directed therapy in the treatment of severe sepsis and septic shock. NEJM 2001; 345: 1368-1377.